IL3RA
Interleukin-3 receptor subunit alpha
Also known as: CD123, IL3RA_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P26951
- Gene
- IL3RA
- Ensembl
- ENSG00000185291
- Chromosome
- X
- Canonical length
- 378 aa
- Protein class
- CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins
OverviewNCBI Gene
The protein encoded by this gene is an interleukin 3 specific subunit of a heterodimeric cytokine receptor. The receptor is comprised of a ligand specific alpha subunit and a signal transducing beta subunit shared by the receptors for interleukin 3 (IL3), colony stimulating factor 2 (CSF2/GM-CSF), and interleukin 5 (IL5). The binding of this protein to IL3 depends on the beta subunit. The beta subunit is activated by the ligand binding, and is required for the biological activities of IL3. This gene and the gene encoding the colony stimulating factor 2 receptor alpha chain (CSF2RA) form a cytokine receptor gene cluster in a X-Y pseudoautosomal region on chromosomes X or Y. Alternatively spliced transcript variants encoding distinct isoforms have been found. [provided by RefSeq, Jun 2012]
Canonical amino-acid sequenceUniProt
378 residues, UniProt reviewed canonical sequence.
>P26951|IL3RA
1 MVLLWLTLLL IALPCLLQTK EDPNPPITNL RMKAKAQQLT WDLNRNVTDI ECVKDADYSM
61 PAVNNSYCQF GAISLCEVTN YTVRVANPPF STWILFPENS GKPWAGAENL TCWIHDVDFL
121 SCSWAVGPGA PADVQYDLYL NVANRRQQYE CLHYKTDAQG TRIGCRFDDI SRLSSGSQSS
181 HILVRGRSAA FGIPCTDKFV VFSQIEILTP PNMTAKCNKT HSFMHWKMRS HFNRKFRYEL
241 QIQKRMQPVI TEQVRDRTSF QLLNPGTYTV QIRARERVYE FLSAWSTPQR FECDQEEGAN
301 TRAWRTSLLI ALGTLLALVC VFVICRRYLV MQRLFPRIPH MKDPIGDSFQ NDKLVVWEAG
361 KAGLEECLVT EVQVVQKTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against IL3RA can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.39
- Highest tissue expression
- 27 nTPM
Expression across tissuesHPA
Tissue
- adipose tissue: 27 nTPM
- lung: 27 nTPM
- bone marrow: 24 nTPM
- lymph node: 23 nTPM
- breast: 22 nTPM
- retina: 20 nTPM
Single-cell type
- pdcs: 993 nCPM
- epicardial cells: 505 nCPM
- oocytes: 180 nCPM
- vascular endothelial cells: 151 nCPM
- cdc: 119 nCPM
- retinal bipolar cells: 105 nCPM
Immune cell
- basophil: 2,669 nTPM
- plasmacytoid DC: 630 nTPM
- eosinophil: 84 nTPM
- non-classical monocyte: 43 nTPM
- intermediate monocyte: 32 nTPM
- myeloid DC: 15 nTPM
Brain region
- white matter: 57 nTPM
- cerebellum: 50 nTPM
- basal ganglia: 45 nTPM
- cerebral cortex: 43 nTPM
- medulla oblongata: 42 nTPM
- pons: 40 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.88
- gnomAD pLI
- 0
- gnomAD missense Z
- -1.5
OntologyGO
Biological processes
- cytokine-mediated signaling pathway
- interleukin-3-mediated signaling pathway
- positive regulation of cell population proliferation
Molecular functions
- cytokine binding
- cytokine receptor activity
- interleukin-3 receptor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of IL3RA in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads IL3RA as an antibody target. Whether an autoantibody or antibody against IL3RA could matter depends on whether native IL3RA is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
IL3RA is annotated at the cell surface, where native IL3RA is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label IL3RA as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...